Search for: "Chen v. Sun" Results 21 - 40 of 64
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jun 2022, 10:50 am by Thorsten Bausch (Hoffmann Eitle)
Swan€ 112 Chinese Patent Law: A Practical Guide by Sun Changlong, Zhang Junjie, Fanwen Kong, Dang Li, Yongbo Li, Zhang Liang (William), Wang Meng, Zhang Qiulin, Wang Rong, Gu Runfeng, Chen Shasha, Lu Weiting, Ge Xiaomei, Yang Yang, He Yibo€ 148 [read post]
Swan€ 112 Chinese Patent Law: A Practical Guide by Sun Changlong, Zhang Junjie, Fanwen Kong, Dang Li, Yongbo Li, Zhang Liang (William), Wang Meng, Zhang Qiulin, Wang Rong, Gu Runfeng, Chen Shasha, Lu Weiting, Ge Xiaomei, Yang Yang, He Yibo€ 148 [read post]
9 Jun 2022, 4:03 am by Linda O'Brien (CCH)
Swan€ 112 Chinese Patent Law: A Practical Guide by Sun Changlong, Zhang Junjie, Fanwen Kong, Dang Li, Yongbo Li, Zhang Liang (William), Wang Meng, Zhang Qiulin, Wang Rong, Gu Runfeng, Chen Shasha, Lu Weiting, Ge Xiaomei, Yang Yang, He Yibo€ 148 [read post]
19 May 2022, 4:45 am by Miquel Montañá (Clifford Chance)
Our last blog entry, UPC: four reasons on why the PPA is not legally in force, published on 21 April 2022, seems to have touched a nerve, as attested by the unprecedented number of comments received, for which this author is very grateful. [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 Chinese Patent Law: A Practical Guide by Sun Changlong, Zhang Junjie, Fanwen Kong, Dang Li, Yongbo Li, Zhang Liang (William), Wang Meng, Zhang Qiulin, Wang Rong, Gu Runfeng, Chen Shasha, Lu… [read post]
., (v) Meiji Seika Pharma Co., Ltd. and (vi) Ohara … Continue reading against a medical use patent of Otsuka Pharmaceutical Co., Ltd. [read post]
22 Mar 2022, 4:38 am by Brian Cordery (Bristows)
“ As regards the 3(c) issue, this provision has been largely left undisturbed since the rulings of the court in Sanofi v Actavis[2] and Boehringer Ingelheim v Actavis[3] which held that even if Article 3(a) was satisfied, in circumstances where a basic patent included a claim to a product comprising an active ingredient which constituted the sole subject matter of the invention and for which the holder of that patent had already obtained an SPC as well as a subsequent claim… [read post]
The Court’s approach to confidentiality Meade J began his analysis with a reminder of the key principles identified by the Court of Appeal in OnePlus v Mitsubishi ([2020] EWCA 1562). [read post]
16 Mar 2022, 8:39 am by Ivan Marinov (Delchev & Partners)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 Chinese Patent Law: A Practical Guide by Sun Changlong, Zhang Junjie, Fanwen Kong, Dang Li, Yongbo Li, Zhang Liang (William), Wang Meng, Zhang Qiulin, Wang Rong, Gu Runfeng, Chen Shasha, Lu… [read post]
The Federal Court decision in Thaler v Commissioner of Patents” analyses the reasoning of Beach J in the Thaler decision at first instance, noting that this decision is the first judicial consideration in Australia relating to the impact of artificial intelligence (AI) on the Australian patent system. [read post]
22 Nov 2020, 4:09 pm by INFORRM
It was held that the natural and ordinary meaning of a social media post by the defendant, Coleen Rooney, was that the claimant had had “consistently and repeatedly betrayed the defendant’s trust over several years by leaking the defendant’s private and personal Instagram posts and stories for publication in The Sun”. [read post]
2 Oct 2019, 10:00 pm
Supreme Court decided Henry Schein, Inc. v. [read post]